What does DR.GOETHALS MIRANDA-OFTALMOGIE do?

DR.GOETHALS MIRANDA-OFTALMOGIE is a specialist medical practice in Beersel. Private Limited, started on 15 January 2009, 1 establishment.

What is the address of DR.GOETHALS MIRANDA-OFTALMOGIE?

The registered office of DR.GOETHALS MIRANDA-OFTALMOGIE is located at L. Devillersstraat 67, 1654 Beersel.

Is DR.GOETHALS MIRANDA-OFTALMOGIE still active?

Yes. According to the CBE (17 September 2026) DR.GOETHALS MIRANDA-OFTALMOGIE is active, legal situation “Normale toestand”, started on 15 January 2009.

Is DR.GOETHALS MIRANDA-OFTALMOGIE registered on Peppol?

Yes, DR.GOETHALS MIRANDA-OFTALMOGIE is registered on the Peppol network with ID 0208:0809123223.

What is the enterprise number of DR.GOETHALS MIRANDA-OFTALMOGIE?

The enterprise number of DR.GOETHALS MIRANDA-OFTALMOGIE is BE0809123223.

When was DR.GOETHALS MIRANDA-OFTALMOGIE founded?

DR.GOETHALS MIRANDA-OFTALMOGIE was founded on 15 January 2009.

Who are the directors of DR.GOETHALS MIRANDA-OFTALMOGIE?

According to the 2025 annual accounts, the directors of DR.GOETHALS MIRANDA-OFTALMOGIE are: Miranda Goethals.

Is DR.GOETHALS MIRANDA-OFTALMOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 January 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR.GOETHALS MIRANDA-OFTALMOGIE make in 2025?

DR.GOETHALS MIRANDA-OFTALMOGIE posted a profit after taxes of € 282,624 in financial year 2025.

What is the revenue of DR.GOETHALS MIRANDA-OFTALMOGIE?

As a small company, DR.GOETHALS MIRANDA-OFTALMOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 418,500.

How many employees does DR.GOETHALS MIRANDA-OFTALMOGIE have?

According to the 2025 annual accounts, DR.GOETHALS MIRANDA-OFTALMOGIE has 0 full-time equivalents (FTE).

DR.GOETHALS MIRANDA-OFTALMOGIE (Private Limited)

Dossier DR.GOETHALS MIRANDA-OFTALMOGIE, printed on 17 September 2026 from databakkes.be/en/0809123223/dr-goethals-miranda-oftalmogie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR.GOETHALS MIRANDA-OFTALMOGIE from Beersel, company number BE0809123223, closed financial year 2025 with a result of € 282,624 after tax. For that financial year DR.GOETHALS MIRANDA-OFTALMOGIE recorded a gross margin of € 418,500 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 256,879 to € 282,624. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.

What it is worth Growing

€ 1.2 million

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 282,624

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 375,309

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 156,295 paid out

55 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 9,404

▼ 57% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 20,188

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4,132

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 61,052

▲ 20% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 296,505 Gross margin 2022: € 296,505 First fiscal year in the series	€ 321,684 Gross margin 2023: € 321,684 ▲ 8% vs 2022 (€ 296,505) Favourable step	€ 386,288 Gross margin 2024: € 386,288 ▲ 20% vs 2023 (€ 321,684) Favourable step	€ 418,500 Gross margin 2025: € 418,500 ▲ 8% vs 2024 (€ 386,288) Favourable step	▲ 8%
Profit after taxes	€ 189,901 Profit after taxes 2022: € 189,901 First fiscal year in the series	€ 211,723 Profit after taxes 2023: € 211,723 ▲ 11% vs 2022 (€ 189,901) Favourable step	€ 256,879 Profit after taxes 2024: € 256,879 ▲ 21% vs 2023 (€ 211,723) Favourable step	€ 282,624 Profit after taxes 2025: € 282,624 ▲ 10% vs 2024 (€ 256,879) Favourable step	▲ 10%
Equity	€ 947,176 Equity 2022: € 947,176 First fiscal year in the series	€ 980,232 Equity 2023: € 980,232 ▲ 3% vs 2022 (€ 947,176) Favourable step	€ 1,034,558 Equity 2024: € 1,034,558 ▲ 6% vs 2023 (€ 980,232) Favourable step	€ 1,160,887 Equity 2025: € 1,160,887 ▲ 12% vs 2024 (€ 1,034,558) Favourable step	▲ 12%
Total debts	€ 216,712 Total debts 2022: € 216,712 First fiscal year in the series	€ 231,157 Total debts 2023: € 231,157 ▲ 7% vs 2022 (€ 216,712) Unfavourable step	€ 269,705 Total debts 2024: € 269,705 ▲ 17% vs 2023 (€ 231,157) Unfavourable step	€ 258,107 Total debts 2025: € 258,107 ▼ 4% vs 2024 (€ 269,705) Favourable step	▼ 4%
Cash	€ 208,631 Cash 2022: € 208,631 First fiscal year in the series	€ 173,160 Cash 2023: € 173,160 ▼ 17% vs 2022 (€ 208,631) Unfavourable step	€ 353,679 Cash 2024: € 353,679 ▲ 104% vs 2023 (€ 173,160) Favourable step	€ 375,309 Cash 2025: € 375,309 ▲ 6% vs 2024 (€ 353,679) Favourable step	▲ 6%
Retained profit	€ 934,776 Retained profit 2022: € 934,776 First fiscal year in the series	€ 967,832 Retained profit 2023: € 967,832 ▲ 4% vs 2022 (€ 934,776) Favourable step	€ 1,022,158 Retained profit 2024: € 1,022,158 ▲ 6% vs 2023 (€ 967,832) Favourable step	€ 1,148,487 Retained profit 2025: € 1,148,487 ▲ 12% vs 2024 (€ 1,022,158) Favourable step	▲ 12%
Dividend	€ 132,619 Dividend 2022: € 132,619 First fiscal year in the series	€ 178,666 Dividend 2023: € 178,666 ▲ 35% vs 2022 (€ 132,619) Unchanged	€ 202,552 Dividend 2024: € 202,552 ▲ 13% vs 2023 (€ 178,666) Unchanged	€ 156,295 Dividend 2025: € 156,295 ▼ 23% vs 2024 (€ 202,552) Unchanged	▼ 23%
Bank debt	€ 13,889 Bank debt 2022: € 13,889 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 13,889) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 20,188 Bank debt 2025: € 20,188 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 1,163,888 Balance sheet total 2022: € 1,163,888 First fiscal year in the series	€ 1,211,390 Balance sheet total 2023: € 1,211,390 ▲ 4% vs 2022 (€ 1,163,888) Unchanged	€ 1,304,263 Balance sheet total 2024: € 1,304,263 ▲ 8% vs 2023 (€ 1,211,390) Unchanged	€ 1,418,994 Balance sheet total 2025: € 1,418,994 ▲ 9% vs 2024 (€ 1,304,263) Unchanged	▲ 9%

Key figures of DR.GOETHALS MIRANDA-OFTALMOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR.GOETHALS MIRANDA-OFTALMOGIE?

What happened at DR.GOETHALS MIRANDA-OFTALMOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 14, 2026 New annual accounts for financial year 2025: profit of € 282,624 (▲ 10% vs 2024). Source: NBB ↗
Jan 15, 2009 New establishment in Beersel. KBO
Jan 15, 2009 Start of the company according to the CBE. KBO
2009 Miranda Goethals became a director. NBB

In short

From € 189,901 profit in 2022 to € 282,624 profit in 2025.

Paid € 415,002 in corporate taxes since 2022.

Best year ever: 2025, with € 282,624 profit.

Paid out € 670,133 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR.GOETHALS MIRANDA-OFTALMOGIE? We notify you, reason included.

Follow DR.GOETHALS MIRANDA-OFTALMOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Miranda Goethals

DR.GOETHALS MIRANDA-OFTALMOGIE

Oogartsen ZB 50%

Behind DR.GOETHALS MIRANDA-OFTALMOGIE is Miranda Goethals. It owns 50% of Oogartsen ZB itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Miranda Goethals

Director

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

L. Devillersstraat 67

1654 Beersel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0809.123.223
VAT number: BE 0809.123.223
Registered office: L. Devillersstraat 67, 1654 Beersel
Names & denominations: DR.GOETHALS MIRANDA-OFTALMOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 January 2009
Peppol: Active · Active since 22 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗